Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 21882530)

1.

[Design, synthesis and evaluation of novel 2H-1, 4-benzodiazepine-2-ones as inhibitors of HIV-1 transcription].

Tang YB, Zhang CM, Fang C, Hu C, Huang L, Chen CH, Xiao ZY.

Yao Xue Xue Bao. 2011 Jun;46(6):688-94. Chinese.

PMID:
21882530
3.

Discovery and characterization of an HIV-1 Tat antagonist.

Hsu MC, Schutt AD, Holly M, Slice LW, Sherman MI, Richman DD, Potash MJ, Volsky DJ.

Biochem Soc Trans. 1992 May;20(2):525-31.

PMID:
1397654
4.

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.

J Virol. 2000 Apr;74(8):3740-51.

5.

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.

Hsu MC, Schutt AD, Holly M, Slice LW, Sherman MI, Richman DD, Potash MJ, Volsky DJ.

Science. 1991 Dec 20;254(5039):1799-802.

PMID:
1763331
6.

Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.

de Arellano ER, Alcamí J, López M, Soriano V, Holguín A.

Antiviral Res. 2010 Nov;88(2):152-9. doi: 10.1016/j.antiviral.2010.08.007. Epub 2010 Aug 14.

PMID:
20713090
7.

Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.

Desai-Yajnik V, Hadzic E, Modlinger P, Malhotra S, Gechlik G, Samuels HH.

J Virol. 1995 Aug;69(8):5103-12.

9.

Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.

Harhaj E, Blaney J, Millhouse S, Sun SC.

Virology. 1996 Feb 1;216(1):284-7.

10.

Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.

Chen S, Chen R, He M, Pang R, Tan Z, Yang M.

Bioorg Med Chem. 2009 Mar 1;17(5):1948-56. doi: 10.1016/j.bmc.2009.01.038. Epub 2009 Jan 23.

PMID:
19217787
11.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

13.

Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.

Coyle-Rink J, Sweet T, Abraham S, Sawaya B, Batuman O, Khalili K, Amini S.

Virology. 2002 Aug 1;299(2):240-7.

15.

trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences.

Zimmermann K, Dobrovnik M, Ballaun C, Bevec D, Hauber J, Böhnlein E.

Virology. 1991 Jun;182(2):874-8.

PMID:
2024503
16.

Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells.

Wortman B, Darbinian N, Sawaya BE, Khalili K, Amini S.

J Virol. 2002 Nov;76(21):11159-65.

18.
19.

The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M.

J Biol Chem. 2001 Sep 21;276(38):35435-43. Epub 2001 Jul 16.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk